Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Ying Zhou,Jason Dang,Kung-Yen Chang,Edwin Yau,Pedro Aza-Blanc,Jorge Moscat,Tariq M. Rana

DOI: https://doi.org/10.1158/0008-5472.22409370.v1

2023-01-01

Abstract:Legend for Supplementary Figures S1-S8

What problem does this paper attempt to address?

Supplementary Figure S2 from Mir-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Ying Zhou,Jason Dang,Kung-Yen Chang,Edwin Yau,Pedro Aza-Blanc,Jorge Moscat,Tariq M. Rana

DOI: https://doi.org/10.1158/0008-5472.22409364.v1

2023-01-01

Abstract:Mutation Background of Non-Small Cell Lung Cancer Lines.
Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Yifan Wang,Nan Li,Jinyu Wen,Weiye Deng,Rui Ye,Xu Cai,Yawei Qiao,Amrish Sharma,Ming Zhang,Mien‐Chie Hung,Steven H. Lin

DOI: https://doi.org/10.1158/1078-0432.22469730.v1

2023-01-01

Abstract:Supplementary figure legends
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Jongchan Kim,Ashley N. Siverly,Dahu Chen,Min Wang,Yuan,Yumeng Wang,Hyemin Lee,Jinsong Zhang,William J. Muller,Han Liu,Boyi Gan,Xianbin Yang,Yeneng Sun,M. James You,Ma Li

DOI: https://doi.org/10.1158/0008-5472.22413063.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S11
Supplementary Figures 1-3 from the Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer

Kun Guo,Jiujie Cui,Ming Quan,Dacheng Xie,Zhiliang Jia,Daoyan Wei,Liang Wang,Yong Gao,Qingyong Ma,Keping Xie

DOI: https://doi.org/10.1158/1078-0432.22462092.v1

2023-01-01

Abstract:Supplementary Figure S1. Expression of MSI2 in PDAC specimens. Supplementary Figure S2. Localization of MSI2 in PDAC cells. Supplementary Figure S3. Co-expression of MSI2 and KLF4 in colon and gastric cancer cells.
Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Yan Kong,Lu Si,Yiqian Li,Xiaowen Wu,Xiaowei Xu,Jie Dai,Huan Tang,Meng Ma,Zhihong Chi,Xinan Sheng,Chuanliang Cui,Jun Guo

DOI: https://doi.org/10.1158/1078-0432.22461800.v1

2023-01-01

Abstract:Figure legends for Supplementary Figure S1 and Figure S2
Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391054

2023-01-01

Abstract:PDF file - 214K
Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Xiaohong Wu,Govind Ragupathi,Katherine S. Panageas,Feng Hong,Philip O. Livingston

DOI: https://doi.org/10.1158/1078-0432.22446662

2023-01-01

Abstract:Legend for supplementary figures - PDF file 62K, Supplementary Figure Legend
Supplementary Figure Legend from Enhanced PI3K P110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a P110α-Selective PI3K Inhibitor

Samuel W. Brady,Jian Zhang,Daniel Seok,Hai Wang,Dihua Yu

DOI: https://doi.org/10.1158/1535-7163.22503321

2023-01-01

Abstract:PDF - 76K, Legends for Supplementary Figures 1-9.
Supplementary Figure from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis

Ling-Yu Zhu,Jun-Bo Yuan,Li Zhang,Chun-Xiao He,Xiao Lin,Bin Xu,Guang-Hui Jin

DOI: https://doi.org/10.1158/0008-5472.22432688

2023-01-01

Abstract:Supplementary Figure from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis
Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Peng Yuan,Xiao-Hong He,Ye-Fei Rong,Jing Cao,Yong Li,Yun-Ping Hu,Yingbin Liu,Dangsheng Li,Wenhui Lou,Mo-Fang Liu

DOI: https://doi.org/10.1158/0008-5472.22413540

2023-01-01

Abstract:This file contains Materials and Methods that are involved in the figures of the main text and supplementary information. These materials and methods include information of plasmid constructs, cell transfection and viral transduction, RNA preparation and qRT-PCR, luciferase reporter assay, ChIP assay, therapeutic experiments in mice, and immunohistochemistry and in situ hybridization.
Supplementary Figure Legend from Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

Ninghui Mao,Dong Gao,Wenhuo Hu,Sunyana Gadal,Haley Hieronymus,Shangqian Wang,Young Sun Lee,Patrick Sullivan,Zeda Zhang,Danielle Choi,Neal Rosen,Charles L. Sawyers,Anuradha Gopalan,Yu Chen,Brett S. Carver

DOI: https://doi.org/10.1158/0008-5472.22426324.v1

2023-01-01

Abstract:Figure Legend for supplementary figures
Supplementary Figure Legend from VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells

Xiangcang Ye,Fan,Rajat Bhattacharya,Seth Bellister,Delphine R. Boulbes,Rui Wang,Ling Xia,Cristina Ivan,Xiaofeng Zheng,George A. Calin,Jing Wang,Xiongbin Lu,Lee M. Ellis

DOI: https://doi.org/10.1158/1541-7786.22511929

2023-01-01

Abstract:Supplementary Figure Legend. Supplementary Figure Legend
Supplementary Figure Legends 1-4 from the Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating Cdc42 Recruitment and Activity

Shumin Zhang,Katherine Schafer-Hales,Fadlo R. Khuri,Wei Zhou,Paula M. Vertino,Adam I. Marcus

DOI: https://doi.org/10.1158/0008-5472.22374815

2023-01-01

Abstract:Supplementary Figure Legends 1-4 from The Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating cdc42 Recruitment and Activity
Supplementary Figures and Legends from Targeting PRPK Function Blocks Colon Cancer Metastasis

Tatyana Zykova,Feng Zhu,Lei Wang,Haitao Li,Do Young Lim,Ke Yao,Eunmiri Roh,Sang-Pil Yoon,Hong-Gyum Kim,Ki Beom Bae,Weihong Wen,Seung Ho Shin,Janos Nadas,Yan Li,Weiya Ma,Ann M. Bode,Zigang Dong

DOI: https://doi.org/10.1158/1535-7163.22504792.v1

2023-01-01

Abstract:This file contains 7 Supplementary Figures and associated legends: Supplementary Figure 1. Characterization of the antibody to detect phosphorylated Ser250of PRPK (related to Figure 1B, upper). Supplementary Figure 2. PRPK induces metastasis of colon cancer cells to the liver. Supplementary Figure 3. PRPK induces lung metastasis of human HCT116 or mouse CT26 colon cancer cells. Supplementary Figure 4. EGF induces phosphorylation of PRPK and surviving ex vivo and the combination of 5-FU and FA show synergistic effects against colon cancer growth. Supplementary Figure 5. Pre-treatment with FA combined with 5-FU suppresses colon lung metastasis in mice. Supplementary Figure 6. FA combined with 5-FU suppresses colon lung metastasis in mice Supplementary Figure 7. PRPK regulated colon cancer metastasis independently of p53 status.
Legend for Supplementary Figures from Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma

Tongxin Liu,Quanquan Sun,Qi Li,Hua Yang,Yuqin Zhang,Rong Wang,Xiaoshan Lin,Dong Xiao,Yawei Yuan,Longhua Chen,Wei Wang

DOI: https://doi.org/10.1158/1535-7163.22502823

2023-01-01

Abstract:Supplementary Figure legends
Supplementary Figure Legends from Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth

K. Mark Parnell,Jason M. Foulks,Rebecca N. Nix,Adrianne Clifford,Jeremy Bullough,Bin Luo,Anna V. Senina,David Vollmer,Jihua Liu,Virgil McCarthy,Yong Xu,Michael Saunders,Xiaohui Liu,Scott Pearce,Kevin B. Wright,Marc O’Reilly,Michael V. McCullar,Koc-Kan Ho,Steven B. Kanner

DOI: https://doi.org/10.1158/1535-7163.22499760.v1

2023-01-01

Abstract:Supplementary Figure Legends - PDF file 41K, Legends for supplemental figures 1-4
Supplementary Figure Legend from VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth

Natasha Y. Frank,Tobias Schatton,Soo Kim,Qian Zhan,Brian J. Wilson,Jie Ma,Karim R. Saab,Veronika Osherov,Hans R. Widlund,Martin Gasser,Ana-Maria Waaga-Gasser,Thomas S. Kupper,George F. Murphy,Markus H. Frank

DOI: https://doi.org/10.1158/0008-5472.22389243

2023-01-01

Abstract:Supplementary Figure Legend from VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.

Supplementary Figure Legends from miR-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Supplementary Figure S2 from Mir-1298 Inhibits Mutant KRAS-Driven Tumor Growth by Repressing FAK and LAMB3

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure Legends from Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non–Small Cell Lung Cancer

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

Supplementary Figures 1-3 from the Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer

Figure Legends for Supplementary Figures from Analysis of Mtor Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced &lt;i&gt;let-7g&lt;/i&gt; Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplementary Figure Legend from Enhanced PI3K P110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a P110α-Selective PI3K Inhibitor

Supplementary Figure from Loss of MLL Induces Epigenetic Dysregulation of Rasgrf1 to Attenuate Kras-Driven Lung Tumorigenesis

Supplemental Materials and Methods from KRAS/NF-κB/YY1/miR-489 Signaling Axis Controls Pancreatic Cancer Metastasis

Supplementary Figure Legend from Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2

Supplementary Figure Legend from VEGFR-1 Pseudogene Expression and Regulatory Function in Human Colorectal Cancer Cells

Supplementary Figure Legends 1-4 from the Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating Cdc42 Recruitment and Activity

Supplementary Figures and Legends from Targeting PRPK Function Blocks Colon Cancer Metastasis

Legend for Supplementary Figures from Dual PI3K/mTOR Inhibitors, GSK2126458 and PKI-587, Suppress Tumor Progression and Increase Radiosensitivity in Nasopharyngeal Carcinoma

Supplementary Figure Legends from Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth

Supplementary Figure Legend from VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis